"Dual-Hit" Photothermal and Immunogenicity Activation by Structurally Simple Carbon Dots-Doped Hydrogel.

Area of Science:

• Biomedical Engineering
• Materials Science
• Immunotherapy

Background:

• Effective cancer treatment requires combining localized therapies with systemic immunotherapies.
• Current treatments often struggle to achieve both tumor destruction and long-term immune memory.

Purpose of the Study:

• To develop a synergistic "dual-hit" photothermal-immunotherapy for enhanced tumor treatment.
• To create a multifunctional hydrogel platform for localized drug delivery and thermal ablation.

Main Methods:

• Fabrication of a carbon dot-doped polymeric hydrogel loaded with oxaliplatin.
• Application of laser irradiation for photothermal ablation and controlled drug release.
• Evaluation of the therapeutic efficacy in tumor-bearing mouse models.

Main Results:

• The hydrogel successfully achieved initial photothermal ablation of tumors.
• Released oxaliplatin induced immunogenic cell death, activating a sustained antitumor immune response.
• The "dual-hit" strategy demonstrated significant efficacy in preclinical tumor models.

Conclusions:

• The developed hydrogel represents a promising platform for synergistic photothermal-immunotherapy.
• Combining localized ablation with chemotherapy-induced immunogenic cell death offers a potent strategy for cancer treatment.
• This approach holds potential for generating long-lasting anti-tumor immunity.